Shattuck Labs (STTK) Cash from Operations (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Cash from Operations of 13424000.0 for Q1 2026, down 11.57% year-over-year from 15180222.56 in Q1 2025, and down 58.12% quarter-over-quarter from 8490000.0 in Q4 2025.
Shattuck Labs (STTK) Cash from Operations (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Cash from Operations for 8 consecutive years, with 13424000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations fell 11.57% year-over-year to 13424000.0; the TTM figure through Mar 2026 stood at 41274000.0 (up 26.8% YoY), while the FY2025 annual figure was 39882000.0, up 34.1% from the prior year.
- Cash from Operations retreated to 13424000.0 in Q1 2026 per STTK's latest filing, from 8490000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 8490000.0 in Q4 2025 and bottomed at 28064000.0 in Q3 2022.
- Historically, Cash from Operations has averaged 17032176.47 across 5 years, with a median of 16316000.0 in 2022.
- Annual changes were most pronounced in 2022 — Cash from Operations sank 137.41% — and 2025, when it jumped 51.12%.
- Shattuck Labs' Cash from Operations stood at 23841000.0 in 2022, then grew by 18.55% to 19419000.0 in 2023, then increased by 10.55% to 17370000.0 in 2024, then surged by 51.12% to 8490000.0 in 2025, then slumped by 58.12% to 13424000.0 in 2026.
- Business Quant data shows STTK's Cash from Operations at 13424000.0 in Q1 2026, 8490000.0 in Q4 2025, and 8929000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Shattuck Labs | 962.96 Mn | 962.96 Mn | - | -10.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.19 Mn |
| Jun 30, 2026 | -10.19 Mn |
| Mar 31, 2026 | -13.42 Mn |
| Mar 31, 2026 | -13.42 Mn |
| Dec 31, 2025 | -8.49 Mn |
| Dec 31, 2025 | -8.49 Mn |
| Sep 30, 2025 | -8.93 Mn |
| Sep 30, 2025 | -8.93 Mn |
| Jun 30, 2025 | -10.43 Mn |
| Jun 30, 2025 | -10.43 Mn |
| Mar 31, 2025 | -12.03 Mn |
| Mar 31, 2025 | -12.03 Mn |
| Dec 31, 2024 | -17.37 Mn |
| Dec 31, 2024 | -17.37 Mn |
| Sep 30, 2024 | -16.07 Mn |
| Sep 30, 2024 | -16.07 Mn |
| Jun 30, 2024 | -10.92 Mn |
| Jun 30, 2024 | -10.92 Mn |
| Mar 31, 2024 | -16.16 Mn |
| Mar 31, 2024 | -16.16 Mn |